Nebenwirkungen · Dacogen
Dacogen 50 mg powder for concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 6
HOS-217998 · Präparat HOS-216153
Table 1: Adverse drug reactions identified with Dacogen Frequency Frequency All Gradesa Grades 3-4a System Organ Class (all Grades) Adverse Drug Reaction (%) (%) Infections and Very common pneumonia* 24 20 infestations urinary tract infection* 15 7 All other infections (viral, 63 39 bacterial, fungal)*, b, c, d Common septic shock* 6 4 sepsis* 9 8 sinusitis 3 1 Neoplasms benign, Not known differentiation syndrome Not known Not known malignant and unspecified (incl. cysts and polyps) Blood and lymphatic Very common febrile neutropaenia* 34 32 disorders neutropaenia* 32 30 thrombocytopaenia*, e 41 38 anaemia 38 31 leukopaenia 20 18 Uncommon pancytopaenia* <1 <1 Immune system Common hypersensitivity including 1 <1 disorders anaphylactic reactionf Metabolism and Very common hyperglycaemia 13 3 nutrition disorders Nervous system Very common headache 16 1 disorders Cardiac disorders Uncommon cardiomyopathy <1 <1 Respiratory, thoracic Very common epistaxis 14 2 and mediastinal Not known interstitial lung disease Not known Not known disorders Gastrointestinal Very common diarrhoea 31 2 disorders vomiting 18 1 nausea 33 <1 Common stomatitis 7 1
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-10-02T12:30:00Z · SHA-256 516610473991e1f96619ec384abed306afe6a8e153f1cb00e60fc72274197f0f · Passage 2a025caa764f8ed1ee9d17dff753f94870bd8592e43535d2bed88ed506ca4a94 · Zeichen 1368–4161 im Abschnitt